Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Urinary Bladder Neoplasms 1 Stomach Neoplasms 1 Polyps 1 Neoplasms 1 Lymphoma, Non-Hodgkin 1 Lymphoma, Follicular 1 Lung Neoplasms 1 Infections 1 Adenomatous Polyposis Coli 1

Interventions

Oxaliplatin 81 S 1 (combination) 55 Capecitabine 44 apatinib 32 Paclitaxel 32 Docetaxel 32 Irinotecan 27 Fluorouracil 22 Drug Therapy 21 sintilimab 20 Cisplatin 20 Leucovorin 16 Hyperthermic Intraperitoneal Chemotherapy 13 XELOX 12 Surgical Procedures, Operative 12 camrelizumab 10 Trastuzumab 10 titanium silicide 9 Tegafur 9 Nivolumab 9 Neoadjuvant Therapy 9 pembrolizumab 8 Laparoscopy 8 Gastrectomy 8 Folfox protocol 7 Chemotherapy, Adjuvant 7 toripalimab 6 tislelizumab 6 Ramucirumab 6 Gastroscopy 6

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Unknown × Stomach Neoplasms × Docosahexaenoic Acids × Clear all

NCT01910948 2013-07-30

PAOPUFAGC

The First Hospital of Jilin University

Phase 4 Unknown

Gastrointestinal

Stomach Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡